Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Renal Protective Effect of Luseogliflozin in Elderly Type 2 Diabetes with Renal Impairment
jRCTs071180077Completed
- Sponsor
- Applicable
- Start
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of luseogliflozin in type 2 diabetes mellitus (T2DM) and diabetic glomerulosclerosis, sponsored by Applicable. Started Aug 2018; status: completed.
02
Drugs
luseogliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)diabetic glomerulosclerosis
Beyond the preview
Go deeper on jRCTs071180077.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs071180077.